4.8 Article

Enantioselective Synthesis of Pactamycin, a Complex Antitumor Antibiotic

Journal

SCIENCE
Volume 340, Issue 6129, Pages 180-182

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1234756

Keywords

-

Funding

  1. National Institute of General Medical Sciences [R01 GM084927]
  2. American Chemical Society Division of Organic Chemistry
  3. NSF

Ask authors/readers for more resources

Medicinal application of many complex natural products is precluded by the impracticality of their chemical synthesis. Pactamycin, the most structurally intricate aminocyclopentitol antibiotic, displays potent antiproliferative properties across multiple phylogenetic domains, but it is highly cytotoxic. A limited number of analogs produced by genetic engineering technologies show reduced cytotoxicity against mammalian cells, renewing promise for therapeutic applications. For decades, an efficient synthesis of pactamycin amenable to analog derivatizations has eluded researchers. Here, we present a short asymmetric total synthesis of pactamycin. An enantioselective Mannich reaction and symmetry-breaking reduction sequence was designed to enable assembly of the entire carbon core skeleton in under five steps and control critical three-dimensional (stereochemical) functional group relationships. This modular route totals 15 steps and is immediately amenable for structural analog synthesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available